<?xml version="1.0" encoding="UTF-8"?>
<p class="p">As shown in 
 <xref ref-type="fig" rid="F2" class="xref">Fig. 2</xref>, compound 1 has alkyl and Pi-alkyl interaction with ALA191, ILE21, PHE149, MET199 and PRO193 of binding site residues of the receptor. There are Pi-sigma, Pi-Pi, alkyl and Pi-alkyl interactions between compound 4 and ILE 215, ALA157, LEU218, PHE149, MET199 and PRO139 as the active site of the receptor. Interactions of compound 2 with receptor include, alkyl and Pi-alkyl with ALA157, MET155, TYR158, ILE215 LEU215 of receptors active site. Compound 3 has alkyl and Pi-alkyl interaction with ILE215, LEU215, PHE149, MET155, TYR158, ALA157 and MET103 of the receptors active site.
</p>
